Diagnosis and Treatment of Myeloproliferative Neoplasms With PCM1-JAK2 Rearrangement: Case Report and Literature Review

Myeloproliferative neoplasm (MPN) with PCM1-JAK2 rearrangement is a rare disease with poor prognosis and lacks uniform treatment guidelines. Several studies confirmed the efficacy of ruxolitinib in hematological malignancies with PCM1-JAK2 fusion, but the efficacy is variable. Here, we report two pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yingxin, Cai, Yifeng, Chen, Jia, Cen, Jiannong, Zhu, Mingqing, Pan, Jinlan, Wu, Depei, Sun, Aining, Chen, Suning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542851/
https://www.ncbi.nlm.nih.gov/pubmed/34707996
http://dx.doi.org/10.3389/fonc.2021.753842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542851/
https://www.ncbi.nlm.nih.gov/pubmed/34707996
http://dx.doi.org/10.3389/fonc.2021.753842

Ejemplares similares